Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | PER2 | O15055 | 2/20 | 0.38 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21727226 | 0.87 | PIK3CD (0.42) | POLBKMT2AMEN1PIK3CDTSHR | |
| SCHEMBL20089835 | 0.87 | POLB (0.40) | POLBKMT2AMEN1PIK3CDTSHR | |
| SCHEMBL22000766 | 0.83 | POLB (0.38) | POLBKMT2AMEN1PIK3CDTSHR | |
| SCHEMBL19762326 | 0.82 | POLB (0.38) | POLBKMT2AMEN1PIK3CDTSHR | |
| SCHEMBL22000371 | 0.82 | KMT2A (0.40) | POLBKMT2AMEN1PIK3CDTSHR | |
| SCHEMBL7937319 | 0.80 | KMT2A (0.51) | POLBKMT2AMEN1PIK3CDTSHR | |
| SCHEMBL12056407 | 0.80 | PIK3CD (0.56) | POLBKMT2AMEN1PIK3CDTSHR | |
| SCHEMBL23854068 | 0.79 | PIK3CD (0.46) | KMT2AMEN1PIK3CDTSHRPER2 | |
| SCHEMBL2790458 | 0.79 | POLB (0.46) | POLBKMT2AMEN1PIK3CDTSHR | |
| Glycerin SCHEMBL28092430 | 0.79 | PIK3CD (0.46) | KMT2AMEN1PIK3CDTSHRPER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552931-B2 | Dihydroxy lactam based polymers, compositions and applications thereof | ISP INVESTMENTS LLC (US) | 2026-02-17 | — | — | US | claimed |
| US-20220315761-A1 | DIHYDROXY LACTAM BASED POLYMERS, COMPOSITIONS AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2022-10-06 | — | — | US | claimed |
| CN-113631632-A | Dihydroxylactam-based polymers, compositions thereof and uses thereof | ISP投资有限公司 | 2021-11-09 | — | — | CN | claimed |
| US-12552931-B2 | Dihydroxy lactam based polymers, compositions and applications thereof | ISP INVESTMENTS LLC (US) | 2026-02-17 | — | — | US | disclosed |
| US-20220315761-A1 | DIHYDROXY LACTAM BASED POLYMERS, COMPOSITIONS AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2022-10-06 | — | — | US | disclosed |
| CN-113631632-A | Dihydroxylactam-based polymers, compositions thereof and uses thereof | ISP投资有限公司 | 2021-11-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552931-B2 | Dihydroxy lactam based polymers, compositions and applications thereof | PARG, GNE, PGLS | POLB 1321/4885KMT2A 2411/4885MEN1 1948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.